{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-026601","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.112719+00:00","generated_at":"2026-06-01T14:55:53.789187+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"ADMA Biologics posts May 2024 corporate presentation; no material updates disclosed","bullets":["Corporate presentation titled 'Realizing the Potential of Specialty Biologics with Groundbreaking Immunotechnology' made available.","Presentation intended for use in discussions with potential investors, strategic partners, and analysts.","No new financial guidance, product milestones, or material operational changes were included in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-026601","json":"https://secwatch.observer/filing/0001140361-24-026601.json","markdown":"https://secwatch.observer/filing/0001140361-24-026601.md","text":"https://secwatch.observer/filing/0001140361-24-026601.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124026601/0001140361-24-026601-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124026601/ef20029374_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T14:55:53.789187+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}